Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 63 out of 100. How common it is

Topic: Risk, prevention and care in population studies

The overall PAF for dementia in Denmark was 37·8% (95% CI 35·6-40·0) for the assessed risk factors. The overall PAF was higher in males, 1948-57 birth cohorts, and individuals with low education. Interpretation These findings reinforce the need for tailored dementia interventions building on country-specific evidence. Our findings on interactions between different risk factors are important for generating novel hypotheses on the mechanisms underlying dementia disorders and highlighting at-risk population groups for whom targeting of one risk factor could reduce the risk associated with the co-occurring factor.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Janbek, J., Laursen, T. M., Jørgensen, K., Jensen, M. M., Eliasen, M. H., Christensen, A. I., et al. (2026). Mapping dementia risk factors and their interactions in Denmark: a nationwide cohort study. The Lancet Public Health. https://doi.org/10.1016/S2468-2667(26)00124-6

Vancouver

Janbek J, Laursen TM, Jørgensen K, Jensen MM, Eliasen MH, Christensen AI, et al. Mapping dementia risk factors and their interactions in Denmark: a nationwide cohort study. The Lancet Public Health. 2026. doi:10.1016/S2468-2667(26)00124-6. PMID: 42425116.

BibTeX

@article{janbek2026-42425116,
  author  = {Janbek, J. and Laursen, T. M. and Jørgensen, K. and Jensen, M. M. and Eliasen, M. H. and Christensen, A. I. and Walsh, S. and Sommerlad, A. and Brayne, C. and Waldemar, G.},
  title   = {{Mapping dementia risk factors and their interactions in Denmark: a nationwide cohort study}},
  journal = {The Lancet Public Health},
  year    = {2026},
  doi     = {10.1016/S2468-2667(26)00124-6},
  pmid    = {42425116},
  url     = {https://doi.org/10.1016/S2468-2667(26)00124-6}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 10 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This nationwide Danish cohort study estimated that the assessed risk factors accounted for 37.8% of dementia cases, with a higher proportion in males, certain birth cohorts and people with low education. The findings support tailored dementia interventions and highlight interactions between risk factors, but they are observational.

Study details

Limitations

Registry diagnoses under-capture mild dementia and some risk factors (for example physical inactivity only in the survey subsample); PAFs assume causality and full removal of risk factors; Danish welfare-state setting.

How this study scored 63/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 7 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multi-centre collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 62 of the 98 points it could be judged on, which is 63 of 100. Total 63 of 100.62 of the 98 points we could judge = 63 of 100

Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomised / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 62 of the 98 points we could judge it on, which is 63 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (The Lancet Public Health)
Journal's citation record 2 / 4 The Lancet Public Health: journal h-index 155 (OpenAlex, 2026-10-29)
Study design 7 / 12 A cohort study following people over time
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 1,753,515 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Gunhild Waldemar: h-index 80 (OpenAlex, whole career)
Institution's track record 2 / 3 University College London: institution h-index 2,029 (OpenAlex)
Multi-centre collaboration 3 / 3 OpenAlex lists 14 institution(s) in 2 countries
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42425116)
Free to read — / 2 Access not recorded — left out of this score
Points 62 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 62 of the 98 points we could judge it on is 63 out of 100.
Total 63 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.

Related studies in How common it is

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Similar studies

More on How common it is

See all studies in How common it is →